ETPrime

Welcure Drugs & Pharmaceuticals Share Price

  • 9.31-0.33 (-3.42%)
  • Volume: 1,09,706
BSE
  • Closed
  • Last Updated On: 01 Aug, 2025, 03:48 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Welcure Drugs & Pharmaceuticals Share Price
  • 9.31-0.33 (-3.42%)
  • Volume: 1,09,706
Advertisment

Welcure Drugs share price insights

View All

  • Meeting Agenda: Quarterly Results & Others. Please add to watchlist to track closely.

  • Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 1.13% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Welcure Drugs & Pharmaceuticals Ltd. share price moved down by -3.42% from its previous close of Rs 9.64. Welcure Drugs & Pharmaceuticals Ltd. stock last traded price is 9.31

    Share PriceValue
    Today/Current/Last-9.31
    Previous Day-9.64

InsightsWelcure Drugs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		23.53
    EPS - TTM
    (₹)    		0.40
    MCap
    (₹ Cr.)    		104.61
    Sectoral MCap Rank
    		132
    PB Ratio
    (x)    		-120.63
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.00
    3 Months-0.23
    6 Months-0.26
    1 Year-0.17
    3 Years-0.16
    		0.00
    VWAP
    (₹)    		9.38
    52W H/L
    (₹)
    15.89 / 6.40

    Welcure Drugs Share Price Returns

    1 Day-3.42%
    1 Week-3.12%
    1 Month-34.8%
    3 Months5.68%
    1 YearN.A.
    3 Years33.38%
    5 Years702.59%

    ET Stock ScreenersTop Score Companies

    Check whether Welcure Drugs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Welcure Drugs News & Analysis

    View all Welcure Drugs Share News & Announcements

    Welcure Drugs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Welcure Drugs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Welcure Drugs Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 1.13% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income23.128.8424.550.000.06
      Total Income Growth (%)161.61-64.00--100.0057.75
      Total Expenses20.587.9222.710.350.07
      Total Expenses Growth (%)159.74-65.110.00366.2218.02
      EBIT2.540.911.84-0.35-0.02
      EBIT Growth (%)177.82-50.27---
      Profit after Tax (PAT)2.540.411.84-0.35-0.02
      PAT Growth (%)513.36-77.48---
      EBIT Margin (%)10.9810.347.49--32.14
      Net Profit Margin (%)10.984.687.49--32.14
      Basic EPS (₹)0.330.040.16-0.26-0.01
      Annual FY 2010 FY 2008 FY 2007
      Total Revenue1.0226.7525.80
      Total Revenue Growth (%)-96.183.6653.11
      Total Expenses2.8028.6426.58
      Total Expenses Growth (%)-90.237.7442.08
      Profit after Tax (PAT)-1.78-1.93-0.87
      PAT Growth (%)---
      Operating Profit Margin (%)-246.64-5.30-2.17
      Net Profit Margin (%)-432.16-7.52-3.53
      Basic EPS (₹)-1.46-1.59-0.72
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue26.460.090.240.110.13
      Total Revenue Growth (%)0.00-60.78125.85-21.3561.13
      Total Expenses23.680.270.140.080.08
      Total Expenses Growth (%)8,768.8497.1666.323.85-15.04
      Profit after Tax (PAT)2.17-0.170.100.020.06
      PAT Growth (%)--271.05331.41-57.21-
      Operating Profit Margin (%)11.320.000.0022.4541.33
      Net Profit Margin (%)8.830.000.0022.4541.33
      Basic EPS (₹)0.36-0.120.080.020.05

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Insights

      • Undertaking New Debt

        Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
      Annual FY 2010 FY 2008 FY 2007
      Total Assets6.9017.3519.48
      Total Assets Growth (%)-60.26-10.957.31
      Total Liabilities7.8110.5310.74
      Total Liabilities Growth (%)-25.86-1.9225.77
      Total Equity-0.916.828.75
      Total Equity Growth (%)-113.36-22.03-9.07
      Current Ratio (x)0.491.421.68
      Total Debt to Equity (x)-2.970.410.43
      Contingent Liabilities---
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets266.981.371.530.100.07
      Total Assets Growth (%)0.00-10.461,430.0042.86250.00
      Total Liabilities164.470.030.010.000.00
      Total Liabilities Growth (%)0.05200.00---100.00
      Total Equity102.511.341.520.090.07
      Total Equity Growth (%)7,550.00-11.841,588.8928.57600.00
      Current Ratio (x)4.411.130.4317.3020.28
      Total Debt to Equity (x)1.200.000.000.000.00
      Contingent Liabilities0.00-0.330.330.33

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2010 FY 2008 FY 2007
      Net Cash flow from Operating Activities0.971.300.39
      Net Cash used in Investing Activities0.190.08-0.14
      Net Cash flow from Financing Activities-1.23-1.43-0.28
      Net Cash Flow-0.07-0.06-0.03
      Closing Cash & Cash Equivalent0.180.100.16
      Closing Cash & Cash Equivalent Growth (%)82.44-36.01-16.48
      Total Debt/ CFO (x)2.812.149.48
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-222.03-0.130.110.020.04
      Net Cash used in Investing Activities-0.060.171.32--
      Net Cash flow from Financing Activities222.20-0.02-1.49--
      Net Cash Flow0.110.02-0.060.020.04
      Closing Cash & Cash Equivalent0.130.020.000.070.05
      Closing Cash & Cash Equivalent Growth (%)510.951,627.12-98.1638.97801.07
      Total Debt/ CFO (x)-0.550.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2010 FY 2008 FY 2007
      Return on Equity (%)0.00-28.32-9.97
      Return on Capital Employed (%)-56.37-14.21-4.29
      Return on Assets (%)-25.74-11.13-4.48
      Interest Coverage Ratio (x)-1.33-2.57-2.19
      Asset Turnover Ratio (x)5.95147.93126.60
      Price to Earnings (x)-2.25-2.89-6.36
      Price to Book (x)-4.390.820.63
      EV/EBITDA (x)-10.71-8.85-85.39
      EBITDA Margin (%)-148.31-3.62-0.43
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)2.11-12.976.7125.3579.39
      Return on Capital Employed (%)1.23-12.976.7125.3579.39
      Return on Assets (%)0.81-12.696.6524.3575.47
      Interest Coverage Ratio (x)0.000.000.000.000.00
      Asset Turnover Ratio (x)0.18--1.24182.60
      Price to Earnings (x)47.17-29.1553.76526.3241.84
      Price to Book (x)1.003.773.57128.5532.98
      EV/EBITDA (x)80.81-36.1851.47499.3340.49
      EBITDA Margin (%)11.350.000.0022.4541.33

    Financial InsightsWelcure Drugs

    • Income (P&L)
    • Balance Sheet

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 1.13% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Undertaking New Debt

        Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Welcure Drugs Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Welcure Drugs Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Welcure Drugs23.53-116.380.00-56.37-25.74520.10-246.64-432.16-1.460.49-2.972.81
          Mangalam Drugs20.960.954.5111.271.83-10.836.192.114.251.040.541.91
          Fervent Syn41.952.826.076.056.05254.999.089.090.681,166.310.000.00
          Lactose (India)24.152.128.7814.703.8635.9011.184.434.101.280.96-192.10
          Samrat Pharma14.711.469.9014.685.858.763.692.4823.022.080.14-0.98
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Mercury Laboratories
          • Bharat Immunological
          • Makers Labs
          • Ind Swift Ltd
          • Source Natural

          Choose from Stocks

            See All Parameters

          Peers InsightsWelcure Drugs

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Welcure Drugs Shareholding Pattern

            • Loading...
              Showing Welcure Drugs Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters0.000.000.000.00
              Pledge0.000.000.000.00
              FII0.000.000.000.00
              DII0.000.000.000.00
              Mutual Funds0.000.000.000.00
              Others100.00100.00100.00100.00
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Others11,23,58,200100.00 %0.00

            Welcure Drugs MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Welcure Drugs News Welcure Drugs Quarterly Results Welcure Drugs Dividend Welcure Drugs Q1 ResultsWelcure Drugs Q2 ResultsWelcure Drugs Q3 ResultsWelcure Drugs Q4 Results

            Welcure Drugs Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Jun 16, 2025May 15, 2025POM-
              May 29, 2025May 20, 2025Board MeetingAudited Results
              May 14, 2025May 09, 2025Board MeetingOthers
              Feb 24, 2025Jan 23, 2025POM-
              Feb 14, 2025Feb 10, 2025Board MeetingQuarterly Results

            • Dividend announcements are not available.

            • All TypesEx-DateRecord DateAnnounced onDetails
              RightsJan 01, 1996Jan 25, 1996Oct 09, 1996Rights ratio: 1 share for every 1 held at a price of Rs 10.0

            About Welcure Drugs

            • Executives

            • Auditors

            • AH

              Altaf Hussain Shah

              Managing Director & CFO
              SC

              Suraj Chagan Solanki

              Non Exe.Non Ind.Director
              AA

              Ashish Abbi

              Ind. Non-Executive Director
              DK

              Deepika Krishnan Iyer

              Ind. Non-Executive Director
              Show More
            • Gupta Rustagi & Co
              v P Gupta & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            Plot No. 55,Office No- 104 First Floor Vijay Block ,Laxmi Nagar,New Delhi, Delhi - 110092

            Contact

            welcuredrugs227@gmail.com

            https://welcuredrugs.com

            More Details

            FAQs about Welcure Drugs share

            • 1. What's Welcure Drugs share price today and what are Welcure Drugs share returns ?
              Welcure Drugs share price is Rs 9.31 as on 01 Aug, 2025, 03:48 PM IST. Welcure Drugs share price is down by 3.42% based on previous share price of Rs 9.43. Welcure Drugs share price trend:
              • Last 3 Months: Welcure Drugs share price moved up by 5.68%
              • Last 3 Years: Welcure Drugs Share price moved up by 33.38%
            • 2. What is Welcure Drugs's 52 week high / low?
              52 Week high of Welcure Drugs share is Rs 15.89 while 52 week low is Rs 6.40
            • 3. What's the market capitalization of Welcure Drugs?
              Within the Pharmaceuticals sector, Welcure Drugs stock has a market cap rank of 132. Welcure Drugs has a market cap of Rs 104.61 Cr.
            • 4. What are the returns for Welcure Drugs share?
              Return Performance of Welcure Drugs Shares:
              • 1 Week: Welcure Drugs share price moved down by 3.12%
              • 3 Month: Welcure Drugs share price moved up by 5.68%
              • 6 Month: Welcure Drugs share price moved down by 3.62%
            • 5. What is the PE & PB ratio of Welcure Drugs?
              The PE ratio of Welcure Drugs stands at 24.39, while the PB ratio is 1.06.

            Trending in Markets

            Top Gainers As on 03:59 PM | 01 Aug 2025

            Syrma SGS Technology748.20
            219.20 (41.44%)
            Schneider1,001.30
            254.35 (34.05%)
            Bosch40,390.00
            8870.00 (28.14%)
            Laurus Labs849.35
            182.60 (27.39%)
            Anand Rathi Wealth2,601.10
            558.20 (27.32%)

            Top Losers As on 03:59 PM | 01 Aug 2025

            Ashok Leyland120.35
            -114.88 (-48.84%)
            Motherson Sumi Wiring India37.52
            -23.99 (-39.00%)
            Motherson Sumi95.54
            -59.70 (-38.46%)
            Indian Energy Exchg132.09
            -58.12 (-30.56%)
            Newgen Software818.15
            -357.75 (-30.42%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Welcure Drugs Share Price
            The Economic Times
            BrowseCompanies: